– Withings, a global leader in connected health, has announced that its Sleep Rx sleep apnea device has received clearance from the U.S. Food and Drug Administration (FDA).

–互联健康领域的全球领导者Withings宣布，其Sleep Rx睡眠呼吸暂停装置已获得美国食品和药物管理局（FDA）的许可。

– Sleep Rx represents a significant advancement in the diagnosis of sleep apnea, offering a more convenient and accurate alternative to traditional in-lab testing.

–Sleep Rx代表了睡眠呼吸暂停诊断的重大进步，为传统的实验室测试提供了更方便，更准确的替代方法。

Addressing the Underdiagnosis of Sleep Apnea

解决睡眠呼吸暂停的诊断不足

Sleep apnea is a serious condition that affects millions of people worldwide. However, it is often underdiagnosed due to the limitations of traditional diagnostic methods. Sleep Rx offers a scalable and accurate solution for home sleep apnea testing.

睡眠呼吸暂停是一种严重的疾病，影响着全世界数百万人。然而，由于传统诊断方法的局限性，它经常被诊断不足。Sleep Rx为家庭睡眠呼吸暂停测试提供了一个可扩展且准确的解决方案。

Key Features & Benefits of Sleep Rx

Sleep Rx的主要功能和优点

Non-intrusive: Sleep Rx is a comfortable and unobtrusive device that fits under any mattress.Comprehensive Analysis: Provides detailed analysis of sleep, breathing, and cardiovascular activity.Accurate Diagnosis: Clinically validated for the diagnosis of sleep apnea.Easy to Use: Requires minimal setup and provides clear, easy-to-understand results..

非侵入性：Sleep Rx是一种舒适且不引人注目的设备，适用于任何床垫下。综合分析：提供睡眠、呼吸和心血管活动的详细分析。准确诊断：临床验证了睡眠呼吸暂停的诊断。易于使用：只需要最少的设置，并提供清晰易懂的结果。。

Improved Diagnosis: Sleep Rx can help to accurately diagnose sleep apnea, even in cases where traditional methods have failed.Increased Access: By offering a home-based testing solution, Sleep Rx can improve access to sleep apnea diagnosis.Improved Patient Outcomes: Early diagnosis and treatment of sleep apnea can lead to better health outcomes..

改进诊断：Sleep Rx可以帮助准确诊断睡眠呼吸暂停，即使在传统方法失败的情况下也是如此。增加访问：通过提供基于家庭的测试解决方案，Sleep Rx可以改善睡眠呼吸暂停诊断的访问。改善患者预后：睡眠呼吸暂停的早期诊断和治疗可以带来更好的健康结果。。

“We’re thrilled to bring Sleep Rx to the U.S. market,” said Antoine Robiliard, VP of Withings Health Solutions. “Enabling earlier and more precise diagnosis, Sleep Rx creates a new sleep apnea diagnosis and management paradigm. We know that a one-night assessment is not sufficient. By enabling more efficient and lower-cost home-based OSA diagnosis, Sleep Rx could not only reduce the staggering $150 billion annual economic burden of undiagnosed sleep apnea but also significantly improve long-term health outcomes.”.

Withings Health Solutions副总裁安托万·罗比利亚德（AntoineRobiliard）表示：“我们很高兴将睡眠处方药推向美国市场。”。“Sleep Rx能够实现更早、更精确的诊断，创造了一种新的睡眠呼吸暂停诊断和管理模式。我们知道，一晚的评估是不够的。通过实现更有效、更低成本的家庭OSA诊断，Sleep Rx不仅可以减轻未确诊睡眠呼吸暂停每年1500亿美元的惊人经济负担，而且可以显着改善长期健康结果。”。